Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cyteir Therapeutics stock

Learn how to easily invest in Cyteir Therapeutics stock.

Cyteir Therapeutics Inc is a biotechnology business based in the US. Cyteir Therapeutics shares (CYT) are listed on the NASDAQ and all prices are listed in US Dollars. Cyteir Therapeutics employs 40 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Cyteir Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CYT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Cyteir Therapeutics stock price (NASDAQ: CYT)

Use our graph to track the performance of CYT stocks over time.

Cyteir Therapeutics shares at a glance

Information last updated 2022-06-25.
Latest market close$3.04
52-week range$1.56 - $23.10
50-day moving average $2.30
200-day moving average $8.82
Wall St. target price$13.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.76

Buy Cyteir Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cyteir Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cyteir Therapeutics price performance over time

Historical closes compared with the close of $3.04 from 2022-07-01

1 week (2022-06-24) 8.96%
1 month (2022-06-02) 54.31%
3 months (2022-04-01) -26.39%
6 months (2021-12-31) -73.26%
1 year (2021-07-02) -84.32%
2 years (2020-06-28) N/A
3 years (2019-06-28) N/A
5 years (2017-06-28) N/A

Cyteir Therapeutics financials

Gross profit TTM $-16,591,000
Return on assets TTM -22.4%
Return on equity TTM -38.06%
Profit margin 0%
Book value $4.95
Market capitalisation $98.8 million

TTM: trailing 12 months

Cyteir Therapeutics share dividends

We're not expecting Cyteir Therapeutics to pay a dividend over the next 12 months.

Have Cyteir Therapeutics's shares ever split?

Cyteir Therapeutics's shares were split on a 2:1 basis on 17 September 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cyteir Therapeutics shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cyteir Therapeutics shares which in turn could have impacted Cyteir Therapeutics's share price.

Cyteir Therapeutics overview

Cyteir Therapeutics, Inc. , a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts. .

Frequently asked questions

What percentage of Cyteir Therapeutics is owned by insiders or institutions?
Currently 11.559% of Cyteir Therapeutics shares are held by insiders and 81.885% by institutions.
How many people work for Cyteir Therapeutics?
Latest data suggests 40 work at Cyteir Therapeutics.
When does the fiscal year end for Cyteir Therapeutics?
Cyteir Therapeutics's fiscal year ends in December.
Where is Cyteir Therapeutics based?
Cyteir Therapeutics's address is: 128 Spring Street, Lexington, MA, United States, 02421
What is Cyteir Therapeutics's ISIN number?
Cyteir Therapeutics's international securities identification number is: US23284P1030

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site